Audit Findings Related to Inadequate Segregation of Strengths
Audit Findings Related to Inadequate Segregation of Strengths: A Step-by-Step GMP Tutorial Step-by-Step GMP Tutorial on Audit Findings Related to Inadequate Segregation of Strengths Effective segregation of different product strengths during pharmaceutical manufacturing is a critical element of Good Manufacturing Practice (GMP). Inadequate segregation can lead to cross-contamination, product mix-ups, regulatory non-compliance, and ultimately risks…
Read More “Audit Findings Related to Inadequate Segregation of Strengths” »